A different role for FDG PET/CT in axillary lymph node staging in breast cancer

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 36, Issue 11, 2009, Pages 1896-1897

  Aukema, Tjeerd S ^a   Straver, Marieke E ^a   Valdés Olmos, Renato A ^a   Vogel, Wouter V ^a  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE;

AXILLARY LYMPH NODE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER STAGING; CLINICAL DECISION MAKING; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; HUMAN; LETTER; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; PATIENT MONITORING; POSITRON EMISSION TOMOGRAPHY; SENTINEL LYMPH NODE BIOPSY;

BREAST NEOPLASMS; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 72149102137     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-009-1211-0     Document Type: Letter

References (5)

1. Heusner TA, Kuemmel S, Hahn S, Koeninger A, Otterbach F, Hamami ME, et al. Diagnostic value of full-dose FDG PET/CT for axillary lymph node staging in breast cancer patients. Eur J Nucl Med Mol Imaging 2009. doi: 10.1007/s00259-009-1145-6.
2. D Fuster J Duch P Paredes M Velasco M Munoz G Santamaria, et al. 2008 Preoperative staging of large primary breast cancer with [18F]fluorodeoxyglucose positron emission tomography/computed tomography compared with conventional imaging procedures J Clin Oncol 26 29 4746 4751 10.1200/JCO.2008.17.1496 10.1200/JCO.2008.17.1496 18695254
3. A Gil-Rendo G Zornoza MJ Garcia-Velloso FM Regueira C Beorlegui M Cervera 2006 Fluorodeoxyglucose positron emission tomography with sentinel lymph node biopsy for evaluation of axillary involvement in breast cancer Br J Surg 93 6 707 712 10.1002/bjs.5338 10.1002/bjs.5338 1:STN:280:DC%2BD283ptVaitQ%3D%3D 16622900 (Pubitemid 43886022)
4. JJ van der Hoeven OS Hoekstra EF Comans R Pijpers RP Boom D van Geldere, et al. 2002 Determinants of diagnostic performance of [F-18]fluorodeoxyglucose positron emission tomography for axillary staging in breast cancer Ann Surg 236 5 619 624 10.1097/00000658-200211000-00012 10.1097/00000658-200211000-00012 12409668 (Pubitemid 35246894)
5. U Veronesi C De Cicco VE Galimberti JR Fernandez N Rotmensz G Viale, et al. 2007 A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastases Ann Oncol 18 3 473 478 10.1093/annonc/ mdl425 10.1093/annonc/mdl425 1:STN:280:DC%2BD2szlt1ajtg%3D%3D 17164229 (Pubitemid 46359625)